Concord Biotech Limited (NSE:CONCORDBIO)
1,209.50
+5.80 (0.48%)
Mar 6, 2026, 1:40 PM IST
-30.78% (1Y)
| Market Cap | 125.93B |
| Revenue (ttm) | 11.59B |
| Net Income (ttm) | 3.13B |
| Shares Out | 104.62M |
| EPS (ttm) | 29.69 |
| PE Ratio | 40.55 |
| Forward PE | 31.03 |
| Dividend | 10.70 (0.89%) |
| Ex-Dividend Date | n/a |
| Volume | 32,077 |
| Average Volume | 1,147,222 |
| Open | 1,203.70 |
| Previous Close | 1,203.70 |
| Day's Range | 1,188.60 - 1,214.00 |
| 52-Week Range | 1,068.60 - 2,150.40 |
| Beta | 0.24 |
| RSI | 50.45 |
| Earnings Date | Feb 11, 2026 |